Panelists discuss potential changes to clinical pathways for Bruton tyrosine kinase (BTK) inhibitor therapies as a result of the Inflation Reduction Act (IRA), focusing on how shifting costs and ...
Forbes contributors publish independent expert analyses and insights. We help organizations achieve their impact vision. Through a new partnership with World Education Services, the Sorenson Impact ...
Ghassan Abou-Alfa, MD, MBA, and Mohamed Salem, MD, provide insights regarding potential clinical pathway-driven challenges associated with HCC management. The panel discussion revolved around the ...
Expert consensus recommendations for managing hyperglycemia and rash in patients with PIK3CA-mutated, hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) ...
Social Impact at Kellogg aims to inspire and equip business leaders to create positive, significant and sustainable impact in the world. The Sustainability: Social Impact & Responsible Leadership ...
Over the past 15 years scientists have identified hundreds of regions in the human genome associated with heart attack risk. However, efficient ways to explore how these genetic variants are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results